Thrombolytic Care During Inter-hospital Transfer
NCT02752256 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 76
Last updated 2019-07-05
Summary
Evaluation of ischemic stroke patients receiving tissue plasminogen activator (rtPA) during air ambulance transfer
Conditions
Interventions
- DRUG
-
Tissue Plasminogen Activator
Sponsors & Collaborators
-
University of Iowa
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2017-10-31
- Completion
- 2017-10-31
Countries
- United States
Study Locations
More Related Trials
-
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants
NCT06556446 ·Status: RECRUITING
-
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
NCT07094763 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months
NCT06841978 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Clinical Trial to Evaluate the Safety of Continuous IV Tirofiban in Acute Ischemic Stroke
NCT04818944 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours
NCT07203625 ·Status: RECRUITING ·Phase: PHASE4
-
Safety of Intravenous Thrombolytics in Stroke on Awakening
NCT01643902 ·Status: COMPLETED ·Phase: PHASE2
-
Platelet Function in Patients With Ischemic Stroke Treated With Anti-thrombotic or Thrombolytic
NCT05415150 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Safety and Efficacy Study of High Dose Atorvastatin After Thrombolytic Treatment in Acute Ischemic Stroke
NCT02452502 ·Status: COMPLETED ·Phase: NA
-
Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer
NCT06841965 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Safety Study of a Recombinant Human Plasminogen Activator to Treat Acute Ischemic Stroke.
NCT00418275 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of Intravenous Tissue-type Plasminogen Activator on Acute Ischemic Stroke Patients With Large Vessel Occlusions
NCT04170647 ·Status: UNKNOWN
-
Safety Study of Post Intravenous tPA Monitoring in Ischemic Stroke
NCT02039375 ·Status: COMPLETED ·Phase: NA
-
Safety of Intravenous Thrombolysis for Wake-up Stroke
NCT01183533 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of TB006 in Participants With Acute Ischemic Stroke
NCT05156827 ·Status: WITHDRAWN ·Phase: PHASE2
-
EXtending the Time Window for Thrombolysis in Posterior Circulation Stroke Without Early CT Signs
NCT05429476 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC
NCT06241677 ·Status: RECRUITING ·Phase: NA
-
Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke (AIS)
NCT06040476 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke
NCT00283088 ·Status: COMPLETED ·Phase: PHASE1
-
Intra-arterial Bone-marrow Mononuclear Cells Infusion for Acute Ischemic Stroke
NCT02178657 ·Status: COMPLETED ·Phase: PHASE2
-
Interventional Management of Stroke (IMS) II Study
NCT00243906 ·Status: COMPLETED ·Phase: PHASE2
-
Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke
NCT06781385 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Butyphthalide in Combination With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
NCT03394950 ·Status: COMPLETED ·Phase: PHASE4
-
Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）
NCT05745259 ·Status: UNKNOWN ·Phase: PHASE3
-
Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2)
NCT06010628 ·Status: RECRUITING ·Phase: PHASE4
-
Intravenous Thrombolysis Registry for Chinese Ischemic Stroke Within 4.5 h Onset
NCT02854592 ·Status: COMPLETED